cilastatin has been researched along with Peritoneal Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alhava, E; Haapiainen, R; Havia, T; Kivilaakso, E; Laitinen, S; Matikainen, M; Miettinen, P; Niinikoski, J; Pääkkönen, M | 1 |
| Attanasio, E; Basoli, A; Caprino, L; Carunchio, G; Russo, P | 1 |
2 trial(s) available for cilastatin and Peritoneal Diseases
| Article | Year |
|---|---|
Piperacillin/tazobactam versus imipenem/cilastatin in the treatment of intra-abdominal infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; beta-Lactamase Inhibitors; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Humans; Imipenem; Infusions, Intravenous; Male; Middle Aged; Penicillanic Acid; Peritoneal Diseases; Piperacillin; Tazobactam; Treatment Outcome | 1993 |
Cost-effectiveness study of imipenem/cilastatin versus meropenem in intra-abdominal infections.
Topics: APACHE; Cilastatin; Cost-Benefit Analysis; Decision Trees; Drug Combinations; Female; Health Care Costs; Humans; Imipenem; Infections; Male; Meropenem; Middle Aged; Peritoneal Diseases; Protease Inhibitors; Thienamycins | 2000 |